Article Details
Retrieved on: 2021-04-05 15:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Jan 12 (Reuters) – Britain's GSK and U.S.-based Vir Biotechnology will evaluate one of their monoclonal antibodies in patients with mild to moderate ...
Article found on: fintechzoom.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here